Associated Papers
Imatinib elicited a favorable response in a dog with a mast cell tumor carrying a c-kit c.1523A>T mutation via suppression of constitutive KIT activation.
Yamada O et al.
Veterinary Immunology and Immunopathology, 2011
Mutations in the fifth immunoglobulin-like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours.
Isotani M et al.
British Journal of Haematology, 2010
Select a paper to view details